Koyanagi A, Kajino K, Nojiri S, Abe M, Kobayashi T, Sugitani Y
Juntendo Iji Zasshi. 2024; 69(2):124-136.
PMID: 38854453
PMC: 11153076.
DOI: 10.14789/jmj.JMJ22-0042-OA.
Kojima M, Kajino K, Momose S, Wali N, Hlaing M, Han B
Respir Res. 2020; 21(1):187.
PMID: 32677949
PMC: 7364551.
DOI: 10.1186/s12931-020-01449-2.
Hino O, Abe M, Han B, Yan Y
Cancer Sci. 2019; 110(5):1518-1524.
PMID: 30888083
PMC: 6500980.
DOI: 10.1111/cas.14001.
Imai M, Hino O
Cancer Sci. 2015; 106(11):1483-5.
PMID: 26310516
PMC: 4714696.
DOI: 10.1111/cas.12798.
Fukamachi K, Iigo M, Hagiwara Y, Shibata K, Futakuchi M, Alexander D
PLoS One. 2014; 9(10):e111481.
PMID: 25347530
PMC: 4210215.
DOI: 10.1371/journal.pone.0111481.
Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice.
Zhang J, Bera T, Liu W, Du X, Alewine C, Hassan R
PLoS One. 2014; 9(8):e104388.
PMID: 25118887
PMC: 4132110.
DOI: 10.1371/journal.pone.0104388.
Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma.
Sato T, Suzuki Y, Mori T, Maeda M, Abe M, Hino O
Cancer Med. 2014; 3(5):1377-84.
PMID: 25045139
PMC: 4302688.
DOI: 10.1002/cam4.297.
Retrospective analysis of large-scale research screening of construction workers for the early diagnosis of mesothelioma.
Hirohashi T, Igarashi K, Abe M, Maeda M, Hino O
Mol Clin Oncol. 2014; 2(1):26-30.
PMID: 24649303
PMC: 3915274.
DOI: 10.3892/mco.2013.197.
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
Ito T, Kajino K, Abe M, Sato K, Maekawa H, Sakurada M
Oncol Rep. 2013; 31(1):27-33.
PMID: 24146039
PMC: 3868502.
DOI: 10.3892/or.2013.2803.
The continual search for ideal biomarkers for mesothelioma: the hurdles.
Brims F, Lee Y, Creaney J
J Thorac Dis. 2013; 5(3):364-6.
PMID: 23825777
PMC: 3698297.
DOI: 10.3978/j.issn.2072-1439.2013.04.19.
The N-ERC index is a novel monitoring and prognostic marker for advanced malignant pleural mesothelioma.
Mori T, Tajima K, Hirama M, Sato T, Kido K, Iwakami S
J Thorac Dis. 2013; 5(2):145-8.
PMID: 23585940
PMC: 3621927.
DOI: 10.3978/j.issn.2072-1439.2013.03.03.
Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C, Jia W, Tang Y, Zhao H, Jiang Y, Sun S
J Exp Clin Cancer Res. 2012; 31:84.
PMID: 23034174
PMC: 3585882.
DOI: 10.1186/1756-9966-31-84.
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
Wang K, Bodempudi V, Liu Z, Borrego-Diaz E, Yamoutpoor F, Meyer A
PLoS One. 2012; 7(4):e33214.
PMID: 22485139
PMC: 3317639.
DOI: 10.1371/journal.pone.0033214.
Antitumor activity of anti-C-ERC/mesothelin monoclonal antibody in vivo.
Inami K, Abe M, Takeda K, Hagiwara Y, Maeda M, Segawa T
Cancer Sci. 2010; 101(4):969-74.
PMID: 20100205
PMC: 11158241.
DOI: 10.1111/j.1349-7006.2009.01463.x.
Diagnostic tumor marker of asbestos-related mesothelioma.
Hino O, Maeda M
Environ Health Prev Med. 2009; 13(2):71-4.
PMID: 19568884
PMC: 2698268.
DOI: 10.1007/s12199-007-0014-9.
Chromatin dynamics is correlated with replication timing.
Pliss A, Malyavantham K, Bhattacharya S, Zeitz M, Berezney R
Chromosoma. 2009; 118(4):459-70.
PMID: 19296120
PMC: 2708920.
DOI: 10.1007/s00412-009-0208-6.
Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma.
Hagiwara Y, Hamada Y, Kuwahara M, Maeda M, Segawa T, Ishikawa K
Cancer Sci. 2008; 99(4):666-70.
PMID: 18294289
PMC: 11158223.
DOI: 10.1111/j.1349-7006.2008.00731.x.
Diagnostic biomarker of asbestos-related mesothelioma: example of translational research.
Okio H, Kazu S, Masahiro M
Cancer Sci. 2007; 98(8):1147-51.
PMID: 17532755
PMC: 11159377.
DOI: 10.1111/j.1349-7006.2007.00520.x.
Establishment of the enzyme-linked immunosorbent assay system to detect the amino terminal secretory form of rat Erc/Mesothelin.
Nakaishi M, Kajino K, Ikesue M, Hagiwara Y, Kuwahara M, Mitani H
Cancer Sci. 2007; 98(5):659-64.
PMID: 17425688
PMC: 11160080.
DOI: 10.1111/j.1349-7006.2007.00438.x.
Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients.
Shiomi K, Miyamoto H, Segawa T, Hagiwara Y, Ota A, Maeda M
Cancer Sci. 2006; 97(9):928-32.
PMID: 16776777
PMC: 11158852.
DOI: 10.1111/j.1349-7006.2006.00246.x.